DYNAVAX TECHNOLOGIES CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-11-02: Form 8-K; Period of report 2023-11-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2023-09-13: Form 8-K; Period of report 2023-09-07; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2023-09-01: Form 8-K; Period of report 2023-08-29; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2023-08-03: Form 8-K; Period of report 2023-08-03; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2023-11-02 | 8-K | 2023-11-02 | 2.02 Results of Operations and Financial Condition | 2.02 On November 2, 2023, Dynavax Technologies Corporation ("Dynavax") issued a press release announcing its financial results for the quarter ended September 30, 2023. | dvax-20231102.htm |
| 2023-09-13 | 8-K | 2023-09-07 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | dvax-20230907.htm |
| 2023-09-01 | 8-K | 2023-08-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.. | dvax-20230829.htm |
| 2023-08-03 | 8-K | 2023-08-03 | 2.02 Results of Operations and Financial Condition | 2.02 On August 3, 2023, Dynavax Technologies Corporation ("Dynavax") issued a press release announcing its financial results for the quarter ended June 30, 2023. | dvax-20230803.htm |
| 2023-07-05 | 8-K | 2023-06-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 30, 2023, the Board of Directors (the “Board”) of Dynavax Technologies Corporation (the “Company”) approved the amendment and restatement of the Management Continuity and Severance Agreements for Ryan Spencer, David Novack, and the Company’s other named executive officers (the “Restated Management Agreements”), effective as of July 5, 2023. | dvax-20230630.htm |
| 2023-05-26 | 8-K | 2023-05-26 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 The 2023 Annual Meeting of Stockholders of Dynavax Technologies Corporation (the “Company”) was held on May 26, 2023 in a virtual meeting format, pursuant to notice duly given (the “Annual Meeting”). | dvax-20230526.htm |
| 2023-05-02 | 8-K | 2023-05-02 | 2.02 Results of Operations and Financial Condition | 2.02 On May 2, 2023, Dynavax Technologies Corporation ("Dynavax") issued a press release announcing its financial results for the quarter ended March 31, 2023. | dvax-20230502.htm |
| 2023-02-23 | 8-K | 2023-02-23 | 2.02 Results of Operations and Financial Condition | 2.02 On February 23, 2023, Dynavax Technologies Corporation ("Dynavax") issued a press release announcing its financial results for the fouth quarter and full year ended December 31, 2022. | dvax-20230223.htm |
| 2023-01-09 | 8-K | 2023-01-09 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On January 9, 2023, Dynavax Technologies Corporation ("Dynavax") issued a press release announcing its preliminary unaudited fourth quarter and full year 2022 financial highlights. 7.01 The press release issued by the Company on January 9, 2023, and attached as Exhibit 99.1 to this current report also reported phase 1 shingles topline results. | dvax-20230109.htm |